Search clinical trials for: Anti PD-1
Total 184997 results
-
Fukushima Medical UniversityKanagawa Cancer CenterUnknown
-
Second Affiliated Hospital of Soochow UniversityNot yet recruiting
-
Peking University Third HospitalUnknown
-
First People's Hospital of HangzhouHangzhou Cancer HospitalRecruitingStereotactic Body Radiation Therapy; PD-1 Inhibitor; Hyperthermia; NSCLCChina
-
Peking Union Medical College HospitalRecruitingAnlotinib | Anti-PD-1 Antibody | Advanced Pancreatic CancerChina
-
Greg Durm, MDMerck Sharp & Dohme LLC; Big Ten Cancer Research ConsortiumCompleted
-
Shandong Provincial HospitalUnknownRelapsed/Refractory Non-Hodgkin's LymphomaChina
-
Shanghai Ninth People's Hospital Affiliated to...Fudan University; First Affiliated Hospital of Fujian Medical University; Tianjin... and other collaboratorsRecruitingHead and Neck Squamous Cell CarcinomaChina
-
Symphogen A/SActive, not recruitingSym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor MalignanciesSolid Tumor | Metastatic CancerUnited States, Canada
-
Henlix, IncUnknown
-
Hoffmann-La RocheCompletedBladder CancerUnited States, Spain, United Kingdom, Canada, France, Germany, Italy, Netherlands
-
Novartis PharmaceuticalsCompletedMelanoma | Triple Negative Breast Cancer | Anaplastic Thyroid Cancer | Other Solid Tumors | Non-small Sell Lung Cancer (NSCLC)United States, Italy, Spain, Hungary, Taiwan, Germany, Netherlands, France, Norway, Poland, Thailand, Lebanon, Turkey, Canada
-
Women's Hospital School Of Medicine Zhejiang UniversityRecruitingStudy of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined ChemotherapyGestational Trophoblastic NeoplasiaChina
-
Centre hospitalier de l'Université de Montréal...Bristol-Myers SquibbActive, not recruitingMelanoma | Small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | Brain Metastases, Adult | Clear-Cell Metastatic Renal Cell CarcinomaCanada
-
Matthew GalskyMerck Sharp & Dohme LLC; Hoosier Cancer Research NetworkCompletedBladder Cancer | Urothelial CarcinomaUnited States
-
Shanghai Zhongshan HospitalRecruiting
-
Vestre Viken Hospital TrustOslo University Hospital; University Hospital of North Norway; Helse Stavanger... and other collaboratorsRecruitingOncology | NSCLC Stage IV | NSCLC, Stage IIINorway
-
Merck Sharp & Dohme LLCCompletedCarcinoma, Non-Small-Cell LungUnited States, Ireland, Argentina, Australia, Brazil, Canada, Chile, Colombia, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Mexico, Peru, Poland, South Africa, Spain, Taiwan, Thailand, Turkey, Ukraine, United Kingdom
-
Merck Sharp & Dohme LLCCompletedEsophageal Carcinoma | Esophagogastric Junction CarcinomaChina
-
Merck Sharp & Dohme LLCCompletedEsophageal Carcinoma | Esophagogastric Junction Carcinoma
-
Sun Yat-sen UniversityRecruitingClassical Hodgkin Lymphoma | Refractory or Relapsed Classical Hodgkin LymphomaChina
-
National Cancer Institute (NCI)Recruiting
-
Hangzhou Cancer HospitalAnhui Kedgene Biotechnology Co.,LtdCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Affiliated Cancer Hospital & Institute of Guangzhou...Not yet recruitingNon Small Cell Lung Cancer | EndostatinChina
-
Chinese PLA General HospitalUnknown
-
Huazhong University of Science and TechnologyUnknown
-
Hunan Province Tumor HospitalRecruitingNon-small Cell Lung CancerChina
-
Wuhan Union Hospital, ChinaShanghai Cell Therapy Group Co.,LtdUnknownNon-small-cell Lung Cancer | MesotheliomaChina
-
Zhejiang UniversityRecruitingImmune Checkpoint Inhibitors | Liver InjuryChina
-
Merck Sharp & Dohme LLCCompleted
-
Guangxi Medical UniversityUnknownHepatocellular Carcinoma
-
Merck Sharp & Dohme LLCActive, not recruitingHead and Neck NeoplasmsUnited States, Australia, Austria, Belgium, Brazil, Canada, Colombia, Czechia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Poland, Spain, Taiwan, Turkey, United Kingdom
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
Merck Sharp & Dohme LLCTerminatedAdvanced/Metastatic MelanomaUnited States, Australia, Chile, France, Germany, Israel, Italy, Korea, Republic of, Norway, South Africa, Spain
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityFirst Affiliated Hospital of Jinan University; Shenzhen University General...RecruitingCarcinoma | Digestive System Neoplasms | Intrahepatic Cholangiocarcinoma | First-line Treatment | PD-1 InhibitorChina
-
Mark Garzotto, MDMerck Sharp & Dohme LLC; Astellas Pharma IncRecruitingProstate CancerUnited States
-
Sun Yat-sen UniversityRecruitingColorectal Cancer Metastatic | MSSChina
-
Themis Bioscience GmbHAssign Data Management and Biostatistics GmbH; OptimapharmWithdrawnGastrointestinal CancerGermany
-
Beijing Tongren HospitalNot yet recruitingExtranodal NK/T-cell Lymphoma, Nasal Type
-
Cancer Institute and Hospital, Chinese Academy...The First Affiliated Hospital with Nanjing Medical University; Fujian Cancer... and other collaboratorsRecruitingEsophageal NeoplasmsChina
-
Xiangya Hospital of Central South UniversityRecruitingColonic Neoplasms | Chemotherapy EffectChina
-
AkesoCompletedHCC | Lung Cancer | Solid TumorChina
-
Samsung Medical CenterUnknown
-
Jason J. Luke, MDRecruitingMelanoma | Cervical Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | NSCLC | Advanced Solid Tumors | Cholangiocarcinoma | Bladder Cancer | Renal Cancer | Anal Cancer | Merkel Cell Carcinoma | HNSCCUnited States
-
Peking UniversityUnknownPatients With Digestive System Tumors Resistant to PD-1 Inhibitors
-
Shanghai Zhongshan HospitalRecruiting
-
Shanghai Pulmonary Hospital, Shanghai, ChinaNot yet recruitingExtensive Stage Small Cell Lung Cancer
-
Merck Sharp & Dohme LLCTerminatedAdvanced MelanomaUnited States